Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-29 4:10 pm Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 1,141,000 5.5% | -3,713,252 (-76.49%) | View |
| 2024-04-02 4:36 pm Purchase | 13G | INSTIL BIO INC TIL | BML Investment Partners L.P. | 346,190 5.3% | 346,190 (New Position) | View |
| 2024-03-19 4:29 pm Purchase | 13G | CYTEIR THERAPEUTICS INC CYT | BML Investment Partners L.P. | 3,818,464 10.6% | 348,456 (+10.04%) | View |
| 2024-02-08 11:14 am Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | BML Investment Partners L.P. | 9,395,934 13.3% | 4,895,934 (+108.80%) | View |
| 2024-02-07 2:11 pm Purchase | 13G | TOURMALINE BIO INC TRML | BML Investment Partners L.P. | 245,500 1% | 245,500 (New Position) | View |
| 2024-02-07 1:40 pm Purchase | 13G | CYTEIR THERAPEUTICS INC CYT | BML Investment Partners L.P. | 3,470,008 9.6% | 734,035 (+26.83%) | View |
| 2024-02-07 1:18 pm Sale | 13G | SURROZEN INC SRZN | BML Investment Partners L.P. | 0 0% | -1,669,037 (Position Closed) | View |
| 2024-02-07 1:08 pm Sale | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | BML Investment Partners L.P. | 706,930 4.9% | -151,326 (-17.63%) | View |
| 2024-02-07 12:55 pm Sale | 13G | TILLYS INC TLYS | BML Investment Partners L.P. | 0 0% | -1,234,844 (Position Closed) | View |
| 2024-02-07 12:16 pm Purchase | 13G | ENLIVEN THERAPEUTICS INC ELVN | BML Investment Partners L.P. | 50,000 0.1% | 50,000 (New Position) | View |
| 2024-02-07 11:53 am Purchase | 13G | ELIEM THERAPEUTICS INC ELYM | BML Investment Partners L.P. | 2,350,682 8.5% | 453,068 (+23.88%) | View |
| 2024-02-07 11:36 am Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 4,854,252 2.3% | -2,445,927 (-33.51%) | View |
| 2024-02-07 11:14 am Purchase | 13G | CALCIMEDICA INC CALC | BML Investment Partners L.P. | 220,424 2.1% | 220,424 (New Position) | View |
| 2024-02-07 10:50 am Sale | 13G | QUINCE THERAPEUTICS, INC QNCX | BML Investment Partners L.P. | 0 0% | -1,841,301 (Position Closed) | View |
| 2024-02-07 10:32 am Purchase | 13G | AVROBIO INC AVRO | BML Investment Partners L.P. | 4,401,627 9.9% | 436,231 (+11.00%) | View |
| 2024-02-07 09:25 am Unchanged | 13G | ATEA PHARMACEUTICALS INC AVIR | BML Investment Partners L.P. | 5,602,079 6.7% | 0 (Unchanged) | View |
| 2024-02-07 09:14 am Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | BML Investment Partners L.P. | 5,602,079 6.7% | 1,418,434 (+33.90%) | View |
| 2024-01-16 5:54 pm Purchase | 13G | RENEO PHARMACEUTICALS INC RPHM | BML Investment Partners L.P. | 1,694,229 5.1% | 1,694,229 (New Position) | View |
| 2024-01-16 5:24 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | BML Investment Partners L.P. | 4,500,000 6.4% | 4,500,000 (New Position) | View |
| 2024-01-10 5:39 pm Purchase | 13D | FORTE BIOSCIENCES FBRX | BML Investment Partners L.P. | 1,761,702 4.8% | 26,627 (+1.53%) | View |